Cochrane group | Frequency |
---|---|
Pain, Palliative and Supportive Care Group | 22.0 (9.3%) |
Pregnancy and Childbirth Group | 20.0 (8.5%) |
Gynaecology and fertility group | 15.0 (6.4%) |
Heart Group | 13.0 (5.5%) |
Anaesthesia, Critical and Emergency Care Group | 11.0 (4.7%) |
IBD Group | 11.0 (4.7%) |
Musculoskeletal Group | 10.0 (4.2%) |
Stroke Group | 9.0 (3.8%) |
Kidney and Transplant Group | 9.0 (3.8%) |
Airway group | 8.0 (3.4%) |
Hypertension Group | 8.0 (3.4%) |
Acute Respiratory Infections Group | 7.0 (3.0%) |
Infectious Disease Group | 7.0 (3.0%) |
Vascular Group | 7.0 (3.0%) |
Common Mental Disorders Group | 6.0 (2.5%) |
Drugs and Alcohol Group | 5.0 (2.1%) |
ENT Group | 5.0 (2.1%) |
Neonatal Group | 5.0 (2.1%) |
Neuromuscular group | 5.0 (2.1%) |
Schizophrenia Group | 5.0 (2.1%) |
Skin Group | 5.0 (2.1%) |
Upper GI and Pancreatic Diseases Group | 5.0 (2.1%) |
Developmental, Psychosocial and Learning Problems Group | 3.0 (1.3%) |
Epilepsy Group | 3.0 (1.3%) |
Wounds Group | 3.0 (1.3%) |
Hepato-Biliary Group | 3.0 (1.3%) |
Tobacco Addiction Group | 3.0 (1.3%) |
Bone, Joint and Muscle Trauma Group | 2.0 (0.8%) |
Cystic Fibrosis and Genetic Disorders Group | 2.0 (0.8%) |
Dementia and Cognitive Improvement Group | 2.0(0.8%) |
Eye and Vision Group | 2.0 (0.8%) |
Haematological Malignancies Group | 2.0 (0.8%) |
Incontinence Group | 2.0 (0.8%) |
Metabolic and Endocrine Disorders Group | 2.0 (0.8%) |
Movement Disorders Group | 2.0 (0.8%) |
Other groups | 7.0 (3.0%) |
Total | 236.0 (100.0%) |